[
  {
    "ts": null,
    "headline": "ISRG vs BSX: Which Medical Device Stock Has More Room to Run?",
    "summary": "Boston Scientific offers steady growth with broader exposure, while Intuitive Surgical leads in robotics but faces margin and tariff headwinds.",
    "url": "https://finnhub.io/api/news?id=fbf0e84a8c474b12704b0a9e1e745a85959084a291145b14cb2d53944f85ec93",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750251300,
      "headline": "ISRG vs BSX: Which Medical Device Stock Has More Room to Run?",
      "id": 135358808,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Boston Scientific offers steady growth with broader exposure, while Intuitive Surgical leads in robotics but faces margin and tariff headwinds.",
      "url": "https://finnhub.io/api/news?id=fbf0e84a8c474b12704b0a9e1e745a85959084a291145b14cb2d53944f85ec93"
    }
  },
  {
    "ts": null,
    "headline": "Virtual Incision Appoints Jim Alecxih as Chief Executive Officer",
    "summary": "LINCOLN, Neb., June 18, 2025--Virtual Incision Corporation, the developer of the MIRA Surgical System authorized by the FDA through the De Novo regulatory pathway, today announced the appointment of Jim Alecxih as chief executive officer. Alecxih, a recognized commercial leader in the medical device industry, brings more than 30 years of experience advancing transformative surgical technologies worldwide, including a distinguished tenure at Intuitive Surgical, where he played a pivotal role in t",
    "url": "https://finnhub.io/api/news?id=a7a41e8252aa029c8196886569512354bbcca49cca51368eb5f64abfe72a71eb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750237200,
      "headline": "Virtual Incision Appoints Jim Alecxih as Chief Executive Officer",
      "id": 135358811,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "LINCOLN, Neb., June 18, 2025--Virtual Incision Corporation, the developer of the MIRA Surgical System authorized by the FDA through the De Novo regulatory pathway, today announced the appointment of Jim Alecxih as chief executive officer. Alecxih, a recognized commercial leader in the medical device industry, brings more than 30 years of experience advancing transformative surgical technologies worldwide, including a distinguished tenure at Intuitive Surgical, where he played a pivotal role in t",
      "url": "https://finnhub.io/api/news?id=a7a41e8252aa029c8196886569512354bbcca49cca51368eb5f64abfe72a71eb"
    }
  },
  {
    "ts": null,
    "headline": "Weekly Picks: ? VLS' Solvable Headwinds, VOS' Multi-Year Growth, and ISRG's Valuation Concerns",
    "summary": "Why Vita Life Science’s is a solid business with solvable headwinds, how 2 massive tailwinds will drive multi-year growth for Vossloh, and why Intuitive Surgical’s strengths don’t outweigh the valuation risks.",
    "url": "https://finnhub.io/api/news?id=5b262e1ef36bfacea139a7e5c74084b7aec89bd77813cf1f1e3ddf23a148a1fd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750225344,
      "headline": "Weekly Picks: ? VLS' Solvable Headwinds, VOS' Multi-Year Growth, and ISRG's Valuation Concerns",
      "id": 135349552,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Why Vita Life Science’s is a solid business with solvable headwinds, how 2 massive tailwinds will drive multi-year growth for Vossloh, and why Intuitive Surgical’s strengths don’t outweigh the valuation risks.",
      "url": "https://finnhub.io/api/news?id=5b262e1ef36bfacea139a7e5c74084b7aec89bd77813cf1f1e3ddf23a148a1fd"
    }
  }
]